Interleukin 10 antioxidant effect decreases leukocytes/endothelial interaction induced by tumor necrosis factor α

Shock

Volumn 39, Issue 1, 2013, Pages 83-88

  Huet, Olivier ^a,b   Laemmel, Elisabette ^c   Fu, Yi ^b   Dupic, Laurent ^d   Aprico, Andrea ^b   Andrews, Karen L ^b   Moore, Shirley L ^b   Harrois, Anatole ^a   Meikle, Peter L ^b   Vicaut, Eric ^d   Chin Dusting, Jaye P F ^b   Duranteau, Jacques ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

cytokines; Endothelial cells; inflammation; leukocytes; oxidative stress; reactive oxygen species

Indexed keywords

CERAMIDE; DICHLORODIHYDROFLUORESCEIN DIACETATE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; PHOSPHATIDYLINOSITOL 3 KINASE; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; WORTMANNIN;

ARTICLE; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ENZYME INHIBITION; EX VIVO STUDY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; INFLAMMATION; LEUKOCYTE ADHERENCE; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN FUNCTION; UMBILICAL VEIN ENDOTHELIAL CELL;

ANTIOXIDANTS; CELL ADHESION; CELLS, CULTURED; CERAMIDES; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-10; LEUKOCYTES; OXIDATIVE STRESS; PHOSPHATIDYLINOSITOL 3-KINASES; REACTIVE OXYGEN SPECIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84871985715     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0b013e318278ae36     Document Type: Article

References (35)

1. Spronk PE, Zandstra DF, Ince C: Bench-to-bedside review: Sepsis is a disease of the microcirculation. Crit Care 8:462-468, 2004.
2. Motoyama T, Okamoto K, Kukita I, Hamaguchi M, Kinoshita Y, Ogawa H: Possible role of increased oxidant stress in multiple organ failure after systemic inflammatory response syndrome. Crit Care Med 31:1048-1052, 2003.
3. Huet O, Cherreau C, Nicco C, Dupic L, Conti M, Borderie D, Pene F, Vicaut E, Benhamou D, Mira JP, et al.: Pivotal role of glutathione depletion in plasmainduced endothelial oxidative stress during sepsis. Crit Care Med 36: 2328-2334, 2008.
4. Huet O, Obata R, Aubron C, Spraul-Davit A, Charpentier J, Laplace C, Nguyen-Khoa T, Conti M, Vicaut E, Mira JP, et al.: Plasma-induced endothelial oxidative stress is related to the severity of septic shock. Crit Care Med 35:821-826, 2007.
5. Forceville X: Effects of high doses of selenium, as sodium selenite, in septic shock patients a placebo-controlled, randomized, double-blind, multi-center phase II studyYselenium and sepsis. J Trace ElemMed Biol 21(SUPPL1):62-65, 2007.
6. Valenta J, Brodska H, Drabek T, Hendl J, Kazda A: High-dose selenium substitution in sepsis: A prospective randomized clinical trial. Intensive Care Med 37:808-815, 2011.
7. Reinhart K, Karzai W: Anti-tumor necrosis factor therapy in sepsis: Update on clinical trials and lessons learned. Crit Care Med 29:S121YS125, 2001.
8. Khaper N, Bryan S, Dhingra S, Singal R, Bajaj A, Pathak CM, Singal PK: Targeting the vicious inflammation-oxidative stress cycle for the management of heart failure. Antioxid Redox Signal 13:1033-1049, 2010.
9. Zemse SM, Chiao CW, Hilgers RH, Webb RC: Interleukin-10 inhibits the in vivo and in vitro adverse effects of TNF-alpha on the endothelium of murine aorta. Am J Physiol Heart Circ Physiol 299:H1160YH1167, 2010.
10. Didion SP, Kinzenbaw DA, Schrader LI, Chu Y, Faraci FM: Endogenous interleukin-10 inhibits angiotensin IIYinduced vascular dysfunction. Hypertension 54:619-624, 2009.
11. Zemse SM, Hilgers RH, Simkins GB, Rudic RD, Webb RC: Restoration of endothelin-1Yinduced impairment in endothelium-dependent relaxation by interleukin-10 in murine aortic rings. Can J Physiol Pharmacol 86:557-565, 2008.
12. Kang H, Yang PY, Rui YC: Adenovirus viral interleukin-10 inhibits adhesion molecule expressions induced by hypoxia/reoxygenation in cerebrovascular endothelial cells. Acta Pharmacol Sin 29:50-56, 2008.
13. Giachini FR, Zemse SM, Carneiro FS, Lima VV, Carneiro ZN, Callera GE, Ergul A, Webb RC, Tostes RC: Interleukin-10 attenuates vascular responses to endothelin-1 via effects on ERK1/2Ydependent pathway. Am J Physiol Heart Circ Physiol 296:H489YH496, 2009.
14. Zemse SM, Hilgers RH, Webb RC: Interleukin-10 counteracts impaired endothelium-dependent relaxation induced by Ang II in murine aortic rings. Am J Physiol Heart Circ Physiol 292:H3103YH3108, 2007.
15. Gunnett CA, Heistad DD, Berg DJ, Faraci FM: IL-10 deficiency increases superoxide and endothelial dysfunction during inflammation. Am J Physiol Heart Circ Physiol 279:H1555YH1562, 2000.
16. Kamizato M, Nishida K, Masuda K, Takeo K, Yamamoto Y, Kawai T, Teshima-Kondo S, Tanahashi T, Rokutan K: Interleukin 10 inhibits interferon gamma- and tumor necrosis factor alpha-stimulated activation of NADPH oxidase 1 in human colonic epithelial cells and the mouse colon. J Gastroenterol 44:1172-1184, 2009.
17. Moreira AP, Dias-Melicio LA, Soares AM: Interleukin-10 but not transforming growth factor beta inhibits murine activated macrophages Paracoccidioides brasiliensis killing: Effect on H2O2 and NO production. Cell Immunol 263: 196-203, 2010.
18. Pahan K, Khan M, Singh I: Interleukin-10 and interleukin-13 inhibit proinflammatory cytokine-induced ceramide production through the activation of phosphatidylinositol 3-kinase. J Neurochem 75:576-582, 2000.
19. Singh I, Pahan K, Khan M, Singh AK: Cytokine-mediated induction of ceramide production is redox-sensitive. Implications to proinflammatory cytokine-mediated apoptosis in demyelinating diseases. J Biol Chem 273:20354-20362, 1998.
20. Sakata A, Ochiai T, Shimeno H, Hikishima S, Yokomatsu T, Shibuya S, Toda A, Eyanagi R, Soeda S: Acid sphingomyelinase inhibition suppresses lipopolysaccharide-mediated release of inflammatory cytokines from macrophages and protects against disease pathology in dextran sulphate sodiuminduced colitis in mice. Immunology 122:54-64, 2007.
21. Remick DG, Garg SJ, Newcomb DE, Wollenberg G, Huie TK, Bolgos GL: Exogenous interleukin-10 fails to decrease the mortality or morbidity of sepsis. Crit Care Med 26:895-904, 1998.
22. Bean AG, Freiberg RA, Andrade S, Menon S, Zlotnik A: Interleukin 10 protects mice against staphylococcal enterotoxin BYinduced lethal shock. Infect Immun 61:4937-4939, 1993.
23. Berg DJ, Kuhn R, Rajewsky K, Muller W, Menon S, Davidson N, Grunig G, Rennick D: Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. J Clin Invest 96:2339-2347, 1995.
24. Corda S, Laplace C, Vicaut E, Duranteau J: Rapid reactive oxygen species production by mitochondria in endothelial cells exposed to tumor necrosis factor-alpha is mediated by ceramide. Am J Respir Cell Mol Biol 24:762-768, 2001.
25. Kaur K, Sharma AK, Dhingra S, Singal PK: Interplay of TNF-alpha and IL-10 in regulating oxidative stress in isolated adult cardiac myocytes. J Mol Cell Cardiol 41:1023-1030, 2006.
26. Jamieson S, Flanagan JU, Kolekar S, Buchanan C, Kendall JD, Lee WJ, Rewcastle GW, Denny WA, Singh R, Dickson J, et al.: A drug targeting only p110alpha can block phosphoinositide 3-kinase signalling and tumour growth in certain cell types. Biochem J 438:53-62, 2011.
27. Doukas J, Wrasidlo W, Noronha G, Dneprovskaia E, Fine R, Weis S, Hood J, Demaria A, Soll R, Cheresh D: Phosphoinositide 3-kinase gamma/delta inhibition limits infarct size after myocardial ischemia/reperfusion injury. Proc Natl Acad Sci U S A 103:19866-19871, 2006.
28. Woollard KJ, Sturgeon S, Chin-Dusting JP, Salem HH, Jackson SP: Erythrocyte hemolysis and hemoglobin oxidation promote ferric chloride-induced vascular injury. J Biol Chem 284:13110-13118, 2009.
29. Crawley JB, Williams LM, Mander T, Brennan FM, Foxwell BM: Interleukin-10 stimulation of phosphatidylinositol 3-kinase and p70 S6 kinase is required for the proliferative but not the antiinflammatory effects of the cytokine. J Biol Chem 271:16357-16362, 1996.
30. Haimovitz-Friedman A, Cordon-Cardo C, Bayoumy S, Garzotto M, McLoughlin M, Gallily R, Edwards CK 3rd, Schuchman EH, Fuks Z, Kolesnick R: Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation. J Exp Med 186:1831-1841, 1997.
31. Monick MM, Mallampalli RK, Carter AB, Flaherty DM, McCoy D, Robeff PK, Peterson MW, Hunninghake GW: Ceramide regulates lipopolysaccharideinduced phosphatidylinositol 3-kinase and Akt activity in human alveolar macrophages. J Immunol 167:5977-5985, 2001.
32. Goldsmith M, Avni D, Ernst O, Glucksam Y, Levy-Rimler G, Meijler MM, Zor T: Synergistic IL-10 induction by LPS and the ceramide-1-phosphate analog PCERA-1 is mediated by the cAMP and p38 MAP kinase pathways. Mol Immunol 46:1979-1987, 2009.
33. Goldsmith M, Avni D, Levy-Rimler G, Mashiach R, Ernst O, Levi M, Webb B, MeijlerMM, Gray NS, Rosen H, et al.: A ceramide-1-phosphate analogue, PCERA-1, simultaneously suppresses tumour necrosis factor-alpha and induces interleukin-10 production in activated macrophages. Immunology 127:103-115, 2009.
34. Osuchowski MF, Welch K, Siddiqui J, Remick DG: Circulating cytokine/ inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality.J Immunol 177:1967-1974, 2006
35. Gogos CA, Drosou E, Bassaris HP, Skoutelis A: Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: A marker for prognosis and future therapeutic options. J Infect Dis 181:176-180, 2000.